Article Text

0185: Biweekly Paclitaxel/Carboplatin (Tc) Combination Chemotherapy is Highly Active and Well-Tolerated Treatment in First Line Chemotherapy for Ovarian Cancer

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.